Us Army Med Res Drug Patent Portfolio
Us Army Med Res owns 1 orange book drug protected by 1 US patent Given below is the list of Us Army Med Res's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5607979 | Topical skin protectants | 30 May, 2015 | Expired |
Us Army Med Res's Family Patents
Recent FDA approvals and tentative approvals for Us Army Med Res
This section lists recent FDA approvals and tentative approvals for Lupin, covering innovator and generic drugs with key regulatory details and timelines.
Generic drugs
Includes generic drug submissions with tentative FDA approvals, not yet marketable due to patent or exclusivity restrictions.
| Drug Name | Submission class (FDA) | Submission Category | Submission Date |
|---|---|---|---|
| Methylnaltrexone Bromide |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | - | 12 Aug, 2021 |
Us Army Med Res Drug List
Given below is the complete list of Us Army Med Res's drugs and the patents protecting them.
1. Skin Exposure Reduction Paste Against Chemical Warfare Agents
Skin Exposure Reduction Paste Against Chemical Warfare Agents is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5607979 | Topical skin protectants |
30 May, 2015
(10 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Skin Exposure Reduction Paste Against Chemical Warfare Agents's drug page